NCT07106827 A Study of GV20-0251 in Advanced or Refractory Solid Tumors Status RECRUITING Phase PHASE1
NCT07096362 Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma Status RECRUITING Phase PHASE2
NCT07094204 A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors Status RECRUITING Phase PHASE1
NCT07083479 Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma Status NO_LONGER_AVAILABLE Phase N/A
NCT07076121 A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT07024615 A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer Status RECRUITING Phase PHASE1
NCT07020221 A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06999187 A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas Status RECRUITING Phase PHASE1
NCT06958224 Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers Status NOT_YET_RECRUITING Phase NA
NCT06921928 Study for AZD4360 in Participants With Advanced Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06882746 A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06831136 Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma Status RECRUITING Phase PHASE2
NCT06782412 Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types Status RECRUITING Phase PHASE2/PHASE3
NCT06756074 Reinforced Pancreaticojejunostomy With or Without glubran2 Status RECRUITING Phase PHASE2
NCT06712797 Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center Status ACTIVE_NOT_RECRUITING Phase NA
NCT06710756 Lead-212 PSV359 Therapy for Patients With Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06638866 AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort Status RECRUITING Phase N/A
NCT06607185 A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1